Dyadic International Inc (DYAI)
1.19
+0.07
(+6.25%)
USD |
NASDAQ |
Nov 14, 13:07
Dyadic International Total Liabilities (Quarterly): 7.462M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 7.462M |
| March 31, 2024 | 8.166M |
| December 31, 2023 | 2.341M |
| September 30, 2023 | 1.603M |
| June 30, 2023 | 2.089M |
| March 31, 2023 | 2.007M |
| December 31, 2022 | 2.625M |
| September 30, 2022 | 2.607M |
| June 30, 2022 | 3.662M |
| March 31, 2022 | 2.135M |
| December 31, 2021 | 2.909M |
| September 30, 2021 | 1.963M |
| June 30, 2021 | 3.288M |
| March 31, 2021 | 2.594M |
| December 31, 2020 | 1.626M |
| September 30, 2020 | 1.751M |
| June 30, 2020 | 1.638M |
| March 31, 2020 | 1.136M |
| December 31, 2019 | 1.588M |
| September 30, 2019 | 1.277M |
| June 30, 2019 | 1.450M |
| Date | Value |
|---|---|
| March 31, 2019 | 1.274M |
| December 31, 2018 | 0.8496M |
| September 30, 2018 | 0.8357M |
| June 30, 2018 | 0.4664M |
| March 31, 2018 | 0.9954M |
| December 31, 2017 | 0.7689M |
| September 30, 2017 | 1.066M |
| June 30, 2017 | 1.243M |
| March 31, 2017 | 1.235M |
| December 31, 2016 | 1.010M |
| September 30, 2016 | 0.596M |
| June 30, 2016 | 2.776M |
| March 31, 2016 | 1.296M |
| December 31, 2015 | 2.873M |
| September 30, 2015 | 13.41M |
| December 31, 2014 | 10.80M |
| March 31, 2014 | 12.38M |
| December 31, 2013 | 12.37M |
| September 30, 2013 | 11.33M |
| June 30, 2013 | 11.13M |
| March 31, 2013 | 10.67M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.136M
Minimum
Mar 2020
8.166M
Maximum
Mar 2024
2.800M
Average
2.135M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 9.613M |
| Perspective Therapeutics Inc | 44.92M |
| Protalix BioTherapeutics Inc | 62.96M |
| Electromed Inc | 7.689M |
| Armata Pharmaceuticals Inc | 154.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.63M |
| Shareholders Equity (Quarterly) | 3.168M |
| Debt to Equity Ratio | 1.721 |
| Current Ratio | 5.390 |
| Net Debt Paydown Yield | -2.50% |